Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 227 entries
View as:

Fibrin Sealant in Preventing Fluid Build Up During Surgery in Patients Undergoing Breast Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT01649505 Org: User:
Start: 01/31/11 End: 01/31/12 Due: 01/31/13

Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01422408 Org: User:
Start: 09/30/11 End: 10/31/15 Due: 10/31/16

Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02092324 Org: User:
Start: 07/08/14 End: 01/24/20 Due: 01/24/21

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01532687 Org: User:
Start: 03/13/12 End: 10/31/19 Due: 10/31/20

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03280277 Org: User:
Start: 04/27/18 End: 08/26/21 Due: 08/26/22

Optimizing Body Composition & Health After Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00659906 Org: User:
Start: 01/31/06 End: 01/31/09 Due: 01/31/10

Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE

Phase: N/A Priority: Normal
NCT ID: NCT06011499 Org: User:
Start: 03/12/24 End: 12/31/27 Due: 12/31/28

Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00710151 Org: User:
Start: 07/31/08 End: 12/31/13 Due: 12/31/14

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06320405 Org: User:
Start: 05/21/24 End: 04/01/29 Due: 04/01/30

Enhancing Skin Cancer Early Detection and Treatment in Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT05675709 Org: User:
Start: 04/25/23 End: 06/30/24 Due: 06/30/25

Sulforaphane in Treating Patients With Recurrent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01228084 Org: User:
Start: 11/30/10 End: 05/31/13 Due: 05/31/14

Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trauma

Phase: N/A Priority: Normal
NCT ID: NCT05458869 Org: User:
Start: 09/06/22 End: 05/30/23 Due: 05/30/24

Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01913015 Org: User:
Start: 07/31/13 End: - Due: -

Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT00659334 Org: User:
Start: 08/31/00 End: 03/31/10 Due: 03/31/11

Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00425386 Org: User:
Start: 08/31/06 End: 03/31/14 Due: 03/31/15

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year

Phase: N/A Priority: Normal
NCT ID: NCT04455958 Org: User:
Start: 05/01/21 End: 11/01/21 Due: 11/01/22

Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00662103 Org: User:
Start: 03/31/08 End: 06/30/10 Due: 06/30/11

DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00978562 Org: User:
Start: 08/31/09 End: 12/31/18 Due: 12/31/19

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00281879 Org: User:
Start: 02/28/06 End: 03/31/08 Due: 03/31/09

Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis

Phase: N/A Priority: Normal
NCT ID: NCT01556503 Org: User:
Start: 04/30/11 End: 11/30/13 Due: 11/30/14

Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01441882 Org: User:
Start: 10/31/11 End: 01/01/18 Due: 01/01/19

Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC

Phase: N/A Priority: Normal
NCT ID: NCT04890054 Org: User:
Start: 05/14/21 End: 07/01/24 Due: 07/01/25

Exercising Together During Radiation Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03418025 Org: User:
Start: 11/01/17 End: 10/23/18 Due: 10/23/19

Progressive Resistance Training for the Improvement of Physical Function

Phase: N/A Priority: Normal
NCT ID: NCT04247425 Org: User:
Start: 06/28/19 End: 09/01/21 Due: 09/01/22

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03699995 Org: User:
Start: 05/18/18 End: 12/31/26 Due: 12/31/27